The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Anthelmintic Drugs Market Between 2026 And 2030?
The anthelmintic drugs market has experienced substantial growth in recent years. This market is projected to expand from $3.34 billion in 2025 to $3.53 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.5%. The historical growth of the market can be linked to factors such as a high prevalence of parasitic infections, restricted access to advanced anthelmintic drugs, a continued dependence on traditional drug classes, increasing awareness regarding helminth infections, and the expansion of hospital and clinic infrastructure.
The anthelmintic drugs market size is anticipated to demonstrate robust expansion over the next few years, reaching $4.32 billion by 2030, at a compound annual growth rate (CAGR) of 5.2%. This expected growth during the forecast period is attributable to several factors including the development of novel anthelmintic compounds, the increasing adoption of combination therapies, a rise in veterinary and livestock applications, the expansion of online and retail pharmacy channels, and government initiatives aimed at parasite control programs. Significant trends in the forecast period include the rising prevalence of helminth infections in humans and animals, the growing preference for oral anthelmintics and injectable formulations, an increasing demand for veterinary anthelmintics in livestock management, the broadening reach of retail and online pharmacy channels for anthelmintic drugs, and a strong focus on combination therapies and broad-spectrum anthelmintics.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19291&type=smp
What Leading Drivers Are Supporting The Anthelmintic Drugs Market Expansion?
The widespread occurrence of parasitic infections is projected to drive the expansion of the anthelmintic drugs market in the future. These infections are illnesses stemming from organisms like protozoa, worms, or ectoparasites that inhabit or attach to a host. Factors contributing to parasitic infections include inadequate sanitation, tainted food or water sources, close contact with infected people or animals, insufficient hygiene practices, and limited availability of clean necessities. Anthelmintic medications are employed to manage infections caused by parasitic worms, working by efficiently targeting and expelling these parasites from the host. These drugs function by interfering with the parasites’ normal bodily processes, resulting in their removal or demise. An illustrative example is the data from the Centers for Disease Control and Prevention, a US-based national public health agency, which reported 990 cases of cyclosporiasis acquired in the United States by September 16, 2025, as published in September 2025. Hence, the significant incidence of parasitic infections serves as a primary driver for the anthelmintic drugs market’s growth.
Which Segment Categories Are Included In The Anthelmintic Drugs Market Segment Analysis?
The anthelmintic drugs market covered in this report is segmented –
1) By Drug Class: Benzimidazoles, Macrocyclic lactones, Pyrazinoisoquinolones, Tetrahydropyrimidines, Other Drug Classes
2) By Route Of Administration: Oral, Injectable
3) By Infection Type: Nematode Infections, Cestode Infections, Trematode Infections, Mixed Infections
4) By Distribution Channel: Hospitals And Clinics, Retail Pharmacies, Online Pharmacies, Veterinary Clinics And Supply Stores
5) By Application: Human Anthelmintics, Veterinary Anthelmintics
Subsegments:
1) By Benzimidazoles: Albendazole, Mebendazole, Fenbendazole, Oxfendazole, Thiabendazole
2) By Macrocyclic Lactones: Ivermectin, Moxidectin, Doramectin, Eprinomectin, Milbemycin Oxime
3) By Pyrazinoisoquinolones: Praziquantel, Cysticide
4) By Tetrahydropyrimidines: Pyrantel Pamoate, Pyrantel Tartrate
5) By Other Drug Classes: Imidazothiazoles, Aminoacetonitrile Derivatives, Spiroindoles, Arsenicals
Which Trends Are Impacting The Progress Of The Anthelmintic Drugs Market?
Key players in the anthelmintic drugs market are prioritizing the development of innovative approaches, such as targeted, data-backed deworming programs, to improve parasite management, mitigate drug resistance, and promote the sustainable application of anthelmintics, differentiating from traditional blanket deworming strategies that often involve frequent, unspecific treatments. These precise deworming programs leverage diagnostic evaluations, parasite load assessments, and strategic dosing schedules to optimize treatment efficacy while minimizing environmental impact and resistance risks. For instance, in April 2025, Zoetis Inc., a US-based animal health company, launched the “Buy Less Dewormer” campaign for equine populations, advocating for evidence-based parasite management. The program combines educational resources with guidance on fecal egg count monitoring and strategic anthelmintic selection; its function is to encourage horse owners and veterinarians to administer treatments only when necessary, based on parasite burden and risk assessment. Unique features include integrated educational materials, risk-based treatment recommendations, and support for sustainable anthelmintic stewardship. Applications cover equine herd health management, the prevention of parasite resistance, and optimized deworming schedules. Benefits encompass reduced anthelmintic overuse, enhanced parasite control outcomes, lower costs for owners, and the promotion of long-term drug efficacy.
Who Are The Active Companies Shaping The Anthelmintic Drugs Market?
Major companies operating in the anthelmintic drugs market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Limited, Zoetis Inc., Hetero Labs Limited, Sun Pharmaceutical Industries Ltd., Galderma S.A., Cipla Inc., Ferring Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Mankind Pharma Ltd., Reese Pharmaceutical Company
Get The Full Anthelmintic Drugs Market Report:
https://www.thebusinessresearchcompany.com/report/anthelmintic-drugs-global-market-report
Which Region Leads The Anthelmintic Drugs Market In Terms Of Market Share?
North America was the largest region in the anthelmintic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anthelmintic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Anthelmintic Drugs Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/anthelmintic-drugs-global-market-report
Browse Through More Reports Similar to the Global Anthelmintic Drugs Market 2026, By The Business Research Company
Kidney Cancer Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/kidney-cancer-drugs-global-market-report
Prostate Cancer Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report
Ovarian Cancer Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/ovarian-cancer-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model